{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:23:20Z","timestamp":1791401000376,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11136-019-02340-4","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T10:03:49Z","timestamp":1572516229000},"page":"607-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Cristina","family":"Esquinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Quintano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Roman-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlos","family":"Naberan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Llor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Roncero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Barrecheguren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"2340_CR1","first-page":"324","volume":"53","author":"M Miravitlles","year":"2017","unstructured":"Miravitlles, M., Soler-Catalu\u00f1a, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., et al. (2017). Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary disease. Archivos de Bronconeumologia,53, 324\u2013335.","journal-title":"Archivos de Bronconeumologia"},{"key":"2340_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1477-7525-3-56","volume":"3","author":"E St\u00e5hl","year":"2005","unstructured":"St\u00e5hl, E., Lindberg, A., Jansson, S. A., R\u00f6nmark, E., Svensson, K., Andersson, F., et al. (2005). Health-related quality of life is related to COPD disease severity. Health and Quality of Life Outcomes,3, 56.","journal-title":"Health and Quality of Life Outcomes"},{"key":"2340_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2165\/00019053-200523040-00005","volume":"23","author":"H Doll","year":"2005","unstructured":"Doll, H., & Miravitlles, M. (2005). Quality of life in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature. Pharmacoeconomics,23, 345\u2013363.","journal-title":"Pharmacoeconomics"},{"key":"2340_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/COPD.S32675","volume":"7","author":"P Jones","year":"2012","unstructured":"Jones, P., Miravitlles, M., van der Molen, T., & Kulich, K. (2012). Beyond FEV1 in COPD\u2014a review of patient-reported outcomes and their measurement using a new generation of instruments. The International Journal of Chronic Obstructive Pulmonary Disease,7, 697\u2013709.","journal-title":"The International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"2340_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/15412555.2015.1092953","volume":"13","author":"F Moayeri","year":"2016","unstructured":"Moayeri, F., Hsueh, Y. S., Clarke, P., Hua, X., & Dunt, D. (2016). Health state utility value in chronic obstructive pulmonary disease (COPD); The challenge of heterogeneity: A systematic review and meta-analysis. COPD,13, 380\u2013398.","journal-title":"COPD"},{"key":"2340_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. (1990). EuroQol\u2014a new facility for measurement of health related quality of life. Health Policy,16, 199\u2013208.","journal-title":"Health Policy"},{"key":"2340_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1183\/09031936.00153108","volume":"35","author":"AH Briggs","year":"2010","unstructured":"Briggs, A. H., Glick, H. A., Lozano-Ortega, G., Spencer, M., Calverley, P. M., Jones, P. W., et al. (2010). Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. European Respiratory Journal,35, 532\u2013539.","journal-title":"European Respiratory Journal"},{"key":"2340_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14230","volume":"14","author":"J Cross","year":"2010","unstructured":"Cross, J., Elender, F., Barton, G., Clark, A., Shepstone, L., Blyth, A., et al. (2010). A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX). Health Technology Assessment,14, 1\u2013147.","journal-title":"Health Technology Assessment"},{"key":"2340_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.rmed.2007.11.016","volume":"102","author":"AS Pickard","year":"2008","unstructured":"Pickard, A. S., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine,102, 519\u2013536.","journal-title":"Respiratory Medicine"},{"key":"2340_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1378\/chest.130.4.1117","volume":"130","author":"MP Rutten-van M\u00f6lken","year":"2006","unstructured":"Rutten-van M\u00f6lken, M. P., Oostenbrink, J. B., Tashkin, D. P., Burdkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest,130, 1117\u20131128.","journal-title":"Chest"},{"key":"2340_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000328766","volume":"82","author":"M Miravitlles","year":"2011","unstructured":"Miravitlles, M., Naberan, K., Cantoni, J., & Azpeitia, A. (2011). Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration,82, 402\u2013408.","journal-title":"Respiration"},{"key":"2340_CR12","doi-asserted-by":"publisher","first-page":"992","DOI":"10.5588\/ijtld.15.0021","volume":"19","author":"M Miravitlles","year":"2015","unstructured":"Miravitlles, M., Barrecheguren, M., & Rom\u00e1n-Rodr\u00edguez, M. (2015). Frequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary disease. The International Journal of Tuberculosis and Lung Disease,19, 992\u2013998.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"2340_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1183\/09031936.00087208","volume":"33","author":"M Miravitlles","year":"2009","unstructured":"Miravitlles, M., Llor, C., de Castellar, R., Izquierdo, I., Bar\u00f3, E., & Donado, E. (2009). Validation of the COPD severity score for use in primary care: The NEREA study. European Respiratory Journal,33, 519\u2013527.","journal-title":"European Respiratory Journal"},{"key":"2340_CR14","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.rmed.2014.08.010","volume":"108","author":"M Miravitlles","year":"2014","unstructured":"Miravitlles, M., Molina, J., Quintano, J. A., Campuzano, A., P\u00e9rez, J., & Roncero, C. (2014). Factors associated with depression and severe depression in patients with COPD. Respiratory Medicine,108, 1615\u20131625.","journal-title":"Respiratory Medicine"},{"key":"2340_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994). Validation of a combined comorbidity index. Journal of Clinical Epidemiology,47, 1245\u20131251.","journal-title":"Journal of Clinical Epidemiology"},{"key":"2340_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999). Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax,54, 581\u2013586.","journal-title":"Thorax"},{"key":"2340_CR17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1183\/09031936.04.00014304","volume":"23","author":"BR Celli","year":"2004","unstructured":"Celli, B. R., & MacNee, W. (2004). Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS\/ERS position paper. European Respiratory Journal,23, 932\u2013946.","journal-title":"European Respiratory Journal"},{"key":"2340_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.rmed.2008.12.005","volume":"103","author":"JJ Soler-Catalu\u00f1a","year":"2009","unstructured":"Soler-Catalu\u00f1a, J. J., Mart\u00ednez-Garc\u00eda, M. A., S\u00e1nchez, L. S., Tordera, M. P., & S\u00e1nchez, P. R. (2009). Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients. Respiratory Medicine,103, 692\u2013699.","journal-title":"Respiratory Medicine"},{"key":"2340_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2147\/COPD.S128234","volume":"12","author":"MA Ramon","year":"2017","unstructured":"Ramon, M. A., Esquinas, C., Barrecheguren, M., Pleguezuelos, E., Molina, J., Quintano, J. A., et al. (2017). Self-reported daily walking time in COPD: Relationship with relevant clinical and functional characteristics. The International Journal of Chronic Obstructive Pulmonary Disease,12, 1173\u20131181.","journal-title":"The International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"2340_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"A Zigmond","year":"1983","unstructured":"Zigmond, A., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica,67, 361\u2013370.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"Suppl. 1","key":"2340_CR21","first-page":"79","volume":"112","author":"X Badia","year":"1999","unstructured":"Badia, X., Roset, M., Montserrat, S., Herdman, M., & Segura, A. (1999). The Spanish version of EuroQol: A description and its applications. European Quality of Life scale. Medicina Cl\u00ednica (Barc),112(Suppl. 1), 79\u201385.","journal-title":"Medicina Cl\u00ednica (Barc)"},{"key":"2340_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/thoraxjnl-2015-207782","volume":"71","author":"CM Nolan","year":"2016","unstructured":"Nolan, C. M., Longworth, L., Lord, Joanne, Canavan, J. L., Jones, S. E., Kon, S. S. C., et al. (2016). The EQ-5D-5L health status questionnaire in COPD: Validity, responsiveness and minimum important difference. Thorax,71, 493\u2013500.","journal-title":"Thorax"},{"key":"2340_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/COPD.S76397","volume":"10","author":"M Miravitlles","year":"2015","unstructured":"Miravitlles, M., Huerta, A., Valle, M., Garc\u00eda-Sidro, P., Forn\u00e9, C., Crespo, C., et al. (2015). Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease. The International Journal of Chronic Obstructive Pulmonary Disease,10, 367\u2013377.","journal-title":"The International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"2340_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/thx.2009.115725","volume":"64","author":"M Miravitlles","year":"2009","unstructured":"Miravitlles, M., Soriano, J. B., Garc\u00eda-R\u00edo, F., Mu\u00f1oz, L., Duran-Tauleria, E., Sanchez, G., et al. (2009). Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily activities. Thorax,64, 863\u2013868.","journal-title":"Thorax"},{"key":"2340_CR25","unstructured":"Encuesta Nacional de Salud de Espa\u00f1a (2011\u20132012). Spanish National Health Survey 2011\u20132012. Latest published data, 2013. Accessed October 22, 2017, from \nhttp:\/\/www.ine.es\/jaxi\/menu.do;jsessionid=F1AC5C5327BC8A876380E258216895FA.jaxi01?type=pcaxis&path=\/t15\/p419&file=inebase&L=1\n\n."},{"key":"2340_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1183\/09031936.06.00145104","volume":"27","author":"PW Jones","year":"2006","unstructured":"Jones, P. W., & Agusti, A. G. (2006). Outcomes and markers in the assessment of chronic obstructive pulmonary disease. European Respiratory Journal,27, 822\u2013832.","journal-title":"European Respiratory Journal"},{"key":"2340_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4104\/pcrj.2011.00029","volume":"20","author":"I Tsiligianni","year":"2011","unstructured":"Tsiligianni, I., Kocks, J., Tzanakis, N., Siafakas, N., & van der Molen, T. (2011). Factors that influence disease-specific quality of life or health status in patients with COPD: A review and meta-analysis of Pearson correlations. Primary Care Respiratory Journal,20, 257\u2013268.","journal-title":"Primary Care Respiratory Journal"},{"key":"2340_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11136-005-3215-y","volume":"15","author":"M Miravitlles","year":"2006","unstructured":"Miravitlles, M., Calle, M., Alvarez-Gutierrez, F., Gobartt, E., L\u00f3pez, F., & Mart\u00edn, A. (2006). Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Quality of Life Research,15, 471\u2013480.","journal-title":"Quality of Life Research"},{"issue":"5","key":"2340_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.2112043","volume":"166","author":"A Domingo-Salvany","year":"2006","unstructured":"Domingo-Salvany, A., Lamarca, R., Ferrer, M., Garcia-Aymerich, J., Alonso, J., F\u00e9lez, M., et al. (2006). Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine,166(5), 680\u2013685.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2340_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/COPD.S152955","volume":"13","author":"SB Brien","year":"2018","unstructured":"Brien, S. B., Stuart, B., Dickens, A. P., Kendrick, T., Ejordan, R., Adab, P., et al. (2018). Independent determinants of disease-related quality of life in COPD\u2014scope for non pharmacologic interventions? The International Journal of Chronic Obstructive Pulmonary Disease,13, 247\u2013256.","journal-title":"The International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"2340_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00408-016-9862-7","volume":"194","author":"C Martinez","year":"2016","unstructured":"Martinez, C., Costan, J., Alc\u00e1zar, B., Garcia-Polo, C., Ruiz, L. A., Herrej\u00f3n, A., et al. (2016). Factors associated with depression in COPD: A multicenter study. Lung,194, 335\u2013343.","journal-title":"Lung"},{"key":"2340_CR32","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2147\/COPD.S154791","volume":"13","author":"M Miravitlles","year":"2018","unstructured":"Miravitlles, M., Molina, J., Quintano, J. A., Campuzano, A., P\u00e9rez, J., & Roncero, C. (2018). Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores. The International Journal of Chronic Obstructive Pulmonary Disease,13, 823\u2013831.","journal-title":"The International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"2340_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/15412555.2011.560130","volume":"8","author":"J Sundh","year":"2011","unstructured":"Sundh, J., St\u00e4llberg, B., Lisspers, K., Montgomery, S. M., & Janson, C. (2011). Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD,8, 173\u2013181.","journal-title":"COPD"},{"key":"2340_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/archinte.167.1.60","volume":"167","author":"TP Ng","year":"2007","unstructured":"Ng, T. P., Niti, M., Tan, W. C., Cao, Z., Ong, K. C., & Eng, P. (2007). Depressive symptoms and chronic obstructive pulmonary disease: Effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Archives of Internal Medicine,167, 60\u201367.","journal-title":"Archives of Internal Medicine"},{"key":"2340_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/00008483-200103000-00004","volume":"21","author":"Y Lacasse","year":"2001","unstructured":"Lacasse, Y., Rousseau, L., & Maltais, F. (2001). Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation and Prevention,21, 80\u201386.","journal-title":"Journal of Cardiopulmonary Rehabilitation and Prevention"},{"key":"2340_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12931-017-0548-3","volume":"18","author":"M Miravitlles","year":"2017","unstructured":"Miravitlles, M., & Ribera, A. (2017). Undrestanding the impact of symptoms on the burden of COPD. Respiratory Research,18, 67.","journal-title":"Respiratory Research"},{"key":"2340_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1753465807086097","volume":"1","author":"M Miravitlles","year":"2007","unstructured":"Miravitlles, M., Molina, J., Naberan, K., Cots, J. M., Ros, F., Llor, C., et al. (2007). Factors determining the quality of life of patients with COPD in primary care. Therapeutic Advances in Respiratory Disease,1, 85\u201392.","journal-title":"Therapeutic Advances in Respiratory Disease"},{"issue":"3","key":"2340_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4104\/pcrj.2012.00065","volume":"21","author":"P Jones","year":"2012","unstructured":"Jones, P., Brusselle, G., Dal-Negro, R. W., Ferrer, M., Kardos, P., Levy, M. L., et al. (2012). Patient-centred assessment of COPD in primary care: Experience from a cross-sectional study of health-related quality of life in Europe. Primary Care Respiratory Journal,21(3), 329\u2013336.","journal-title":"Primary Care Respiratory Journal"},{"key":"2340_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00408-015-9838-z","volume":"194","author":"E Pleguezuelos","year":"2016","unstructured":"Pleguezuelos, E., Esquinas, C., Moreno, E., Ll, Guirao, Ortiz, J., Garc\u00eda-Alsina, J., et al. (2016). Muscular dysfunction in COPD: Systemic effect or deconditioning? Lung,194, 249\u2013257.","journal-title":"Lung"},{"key":"2340_CR40","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/15412555.2017.1386643","volume":"14","author":"Z Matkovic","year":"2017","unstructured":"Matkovic, Z., Cvetko, D., Rahelic, D., Esquinas, C., Zarak, M., Miravitlles, M., et al. (2017). Nutritional status of patients with chronic obstructive pulmonary disease in relation to their physical performance. COPD,14, 626\u2013634.","journal-title":"COPD"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-019-02340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-019-02340-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-019-02340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:45:09Z","timestamp":1604018709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-019-02340-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s11136-019-02340-4","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"assertion":[{"value":"18 October 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Marc Miravitlles has received speaker or consulting fees from (in alphabetical order) AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, Laboratorios Esteve, Gebro Pharma, GlaxoSmithKline, Grifols, Menarini, Mereo Biopharma, Novartis, pH Pharma, Rovi, TEVA, Verona Pharma and Zambon, and research grants from GlaxoSmithKline and Grifols, unrelated to this manuscript. The other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study are in accordance with ethical standards of the Institutional Review Board and with the Declaration of Helsinki. All participants within their respective cohorts gave their informed written consent to participate in the original study, and each study was approved by the Research and Ethics Committee of the Hospital Clinic (Barcelona, Spain).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}